ADHD Current Events | ADHD News | 3
|
| Page
3 of
7 |
131 Results |
|
|
|
Sort By:
Page Views | Date |
Couples with Children with ADHD at Risk of Higher Divorce Rates, Shorter Marriages
Parents of a child with attention deficit hyperactivity disorder (ADHD) are nearly twice as likely to divorce by the time the child is 8 years old than parents of children without ADHD, the first study to look at this issue in depth has shown. view more (2008-10-22)
Positive study results for methylphenidate transdermal system
Shire announced at a major medical meeting in Toronto, Canada, that its investigational methylphenidate transdermal system (MTS) demonstrated statistically significant reductions in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) and was generally well tolerated in patients aged 6 to 12 in two clinical trials. view more (2005-10-24)
Did the gene for ADHD help our nomadic ancestors?
An ADHD-associated version of the human gene DRD4 is linked to better health among nomadic tribesmen, but may cause malnourishment in their settled cousins, according to new research by a team directed by an anthropologist at the University of Wisconsin-Milwaukee (UWM). view more (2008-06-17)
Does ADHD look the same in youth of different races?
The research in the article looked at childhood ADHD in underrepresented minorities, reviewing controversy around evaluation, diagnosis, and obstacles faced by families, ending with recommendations for assessment and treatment. view more (2008-03-20)
Brain model enhances understanding of schizophrenia
A new model for the interaction among the nerve cells of the cerebral cortex may be a step on the way to improving treatment for schizophrenia and ADHD. The model, which describes the function of three types of inhibitory nerve cells in the frontal lobe, is being presented in the scientific journal PNAS by researchers from Linköping... view more... (2004-03-05)
Journal SLEEP: Methylphenidate can have sleep benefits in adults with ADHD
Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP. view more (2008-03-03)
Mixed amphetamine salts most effective in the treatment of ADHD in youths
Stimulant medications, such as mixed amphetamine salts (MAS) and methylphenidates are significantly more effective than nonstimulant ADHD medications or novel stimulants, such as modafinil, in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). view more (2006-05-25)
MPH improves vigilance performance of ADHD children with poor sleep
In the first known study of its kind, an article published in the August 1st issue of the journal SLEEP finds that children with attention deficit hyperactivity disorder (ADHD), and whose sleep efficiency is poor, experience significant improvement on some measures of the Continuous Performance Test (CPT) if they are treated with methylphenidate... view more... (2007-08-01)
Overweight mothers run greater risk of having hyperactive children
If a woman is overweight when she becomes pregnant, the probability is much greater that her child will evince ADHD-like symptoms when he/she reaches school age, according to a new Nordic study. view more (2007-11-01)
Stimulant treatment for ADHD has no effect on risk of future substance abuse
A new study finds that the use of stimulant drugs to treat children with ADHD has no effect on their future risk of substance abuse. view more (2008-03-03)
Shire bioequivalence study results of SPD465, investigational drug for adults with ADHD
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that a single once-daily morning dose of the investigational amphetamine compound SPD465, extended release triple-bead mixed amphetamine salts, designed to reduce symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults for up to 16 hours, was bioequivalent to a dose of... view more... (2006-11-17)
New study: Pine bark extract reduces ADHD symptoms in children
A new study to be published in the June 17 edition of the journal of European Child & Adolescent Psychiatry shows a significant reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children after supplementing with Pycnogenol® (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree,... view more... (2006-06-19)
Study raises questions about diagnosis, medical treatment of ADHD
A new UCLA study shows that only about half of children diagnosed with attention-deficit hyperactivity disorder, or ADHD, exhibit the cognitive defects commonly associated with the condition. view more (2008-01-23)
Popular ADHD drug safe and effective for pre-schoolers
A new study by researchers from the Johns Hopkins Children's Center and five other medical centers concludes that carefully measured, low doses of methylphenidate (Ritalin) are safe and effective for attention-deficit and hyperactivity disorder (ADHD) in preschoolers. view more (2006-10-24)
Shire investigational drug (SPD465) designed to reduce ADHD symptoms for up to 16 hours
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced the results of two phase II trials in adults (studies 201 and 203) of the investigational amphetamine compound SPD465 (triple-bead mixed amphetamine salts [MAS]) at a major medical meeting of child and adolescent psychiatrists in San Diego, Calif. view more (2006-11-01)
Computerized training of working memory is a promising therapeutic strategy in ADHD
Attention-deficit/hyperactivity disorder (ADHD), a state of serious impairments in both learning ability and social functioning, is one of many labels for one of the most prevalent conditions in child psychiatry, and, undoubtedly, the most controversial, which partly persists into adulthood. view more (2007-10-15)
Lisdexamfetamine dimesylate in ADHD phase 3 data presented
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that their investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX), yielded a 60 percent improvement in the primary rating scale scores for symptoms of... view more... (2006-10-30)
High Dopamine Transporter Levels Not Correlated with ADHD
Results from a brain-imaging study conducted at the U.S. Department of Energy's Brookhaven National Laboratory in collaboration with Mount Sinai School of Medicine in New York indicate that levels of a brain protein proposed as a diagnostic marker for attention-deficit hyperactivity disorder (ADHD) are not positively correlated with the disease. view more (2006-11-30)
Making sense of ADHD
The research team studied 4000 school children in two age groups, either seven to eight years or 13-14 years. Case studies were carried out on triplets of children, parents and teachers. Although all members of each triplet tended to favour 'within child' explanations as contributing towards attentional and activity difficulties, teachers and... view more... (2001-08-31)
ADDERALL XR significantly improves driving performance, attention in young adults with ADHD
ADDERALL XR® (mixed salts of a single-entity amphetamine product) significantly improved driving performance, cognitive function and attention in young adults with attention-deficit/hyperactivity disorder (ADHD). view more (2005-11-09)
|
|
| Page
3 of
7 |
131 Results |
|
|
|
Sort By:
Page Views | Date |
|
